Deconvolution of spatial sequencing provides accurate characterization of hESC-derived DA transplants in vivo

Mol Ther Methods Clin Dev. 2023 May 4:29:381-394. doi: 10.1016/j.omtm.2023.04.008. eCollection 2023 Jun 8.

Abstract

Cell therapy for Parkinson's disease has experienced substantial growth in the past decades with several ongoing clinical trials. Despite increasing refinement of differentiation protocols and standardization of the transplanted neural precursors, the transcriptomic analysis of cells in the transplant after its full maturation in vivo has not been thoroughly investigated. Here, we present spatial transcriptomics analysis of fully differentiated grafts in their host tissue. Unlike earlier transcriptomics analyses using single-cell technologies, we observe that cells derived from human embryonic stem cells (hESCs) in the grafts adopt mature dopaminergic signatures. We show that the presence of phenotypic dopaminergic genes, which were found to be differentially expressed in the transplants, is concentrated toward the edges of the grafts, in agreement with the immunohistochemical analyses. Deconvolution shows dopamine neurons being the dominating cell type in many features beneath the graft area. These findings further support the preferred environmental niche of TH-positive cells and confirm their dopaminergic phenotype through the presence of multiple dopaminergic markers.

Keywords: Parkinson’s disease; deconvolution; differentiation; disease models; single-cell sequencing; spatial transcriptomics; stem cells; transplantation.